Davol

Davol is a leading medical device company focused on the development of innovative solutions for soft tissue reconstruction and hernia repair. Now a division of Becton, Dickinson and Company (BD) following the acquisition of C. R. Bard, Davol offers an extensive portfolio of synthetic and biologic meshes, fixation systems, and hemostatic agents. The company's flagship products, including the Ventralight and Phasix mesh lines, are designed to improve patient outcomes in complex abdominal wall surgeries. Davol is recognized for its commitment to advancing surgical techniques through clinical research and the development of bioresorbable materials. Its products are used by surgeons worldwide in both open and minimally invasive procedures.